Published in J Interferon Cytokine Res on January 01, 2001
Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol (2001) 3.22
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med (2003) 1.66
Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun (2004) 1.41
Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis. Infect Immun (2002) 1.06
Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob Agents Chemother (2006) 0.96
Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract (2012) 0.95
STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? J Interferon Cytokine Res (2015) 0.80
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination. Mediators Inflamm (2013) 0.77
Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice. PLoS One (2011) 0.76
The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update (2016) 0.76
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85. Cell (1986) 3.80
Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol (1997) 3.70
Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62
Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J Biol Chem (1997) 3.22
Molecular basis of host range variation in avian retroviruses. J Virol (1985) 2.19
Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem (1988) 1.96
Cleavage sites within the poliovirus capsid protein precursors. J Virol (1982) 1.95
The fate of VPg during in vitro translation of poliovirus RNA. FEBS Lett (1981) 1.74
Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein. Virology (1983) 1.61
Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol (1996) 1.60
Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol (1989) 1.36
Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J (2001) 1.34
Regulation of PACE propeptide-processing activity: requirement for a post-endoplasmic reticulum compartment and autoproteolytic activation. Proc Natl Acad Sci U S A (1992) 1.23
Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol (2000) 1.22
Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest (1999) 1.21
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem (1991) 1.21
High level synthesis of immunoglobulins in Chinese hamster ovary cells. J Immunol (1990) 1.16
Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia (1999) 1.16
Protein-linked RNA of poliovirus is competent to form an initiation complex of translation in vitro. Nature (1980) 1.13
IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol (1997) 1.12
Analysis of synthesis, processing, and secretion of proteins expressed in mammalian cells. Methods Enzymol (1990) 1.10
The structure of poliovirus replicative form. Nucleic Acids Res (1980) 1.07
The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood (1991) 1.04
High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology (1995) 1.01
Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest (1998) 0.98
Gene expression analysis in a murine model of allergic asthma reveals overlapping disease and therapy dependent pathways in the lung. Pharmacogenomics J (2006) 0.97
Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis. Osteoarthritis Cartilage (2009) 0.96
Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol (1996) 0.94
Conversion of pre-proparathyroid hormone to proparathyroid hormone by dog pancreatic microsomes. Biochemistry (1978) 0.93
Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology (1999) 0.93
Utilization of the mouse large intestine to select an Escherichia coli F-18 DNA sequence that enhances colonizing ability and stimulates synthesis of type 1 fimbriae. Infect Immun (1993) 0.91
Interleukin-11. A gp130 cytokine. Ann N Y Acad Sci (1998) 0.87
Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells. J Immunol (1999) 0.83
The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease. Expert Opin Investig Drugs (1998) 0.83
In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response. Clin Exp Allergy (2008) 0.83
Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response. Infect Immun (1999) 0.82
Formation in vitro of membrane-bound polysomes containing parathyroid hormone messenger ribonucleic acid. Biochemistry (1979) 0.82
von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood (1999) 0.82
Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity. Toxicol Pathol (2001) 0.81
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses. J Interferon Cytokine Res (2000) 0.79
A CTL assay requiring only 150 microliter of mouse blood. J Immunol Methods (2000) 0.79
IL-12-Dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens. Clin Immunol (2000) 0.78
Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. Pharmacogenomics J (2002) 0.78
Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro. J Interferon Cytokine Res (1998) 0.77
In vivo absorption properties of orally administered recombinant human interleukin-11. Pharm Res (2000) 0.75
Mechanistic toxicogenomic analysis of WAY-144122 administration in Sprague-Dawley rats. Toxicol Appl Pharmacol (2004) 0.75
Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop. Pharmacogenomics J (2006) 0.75
Subcutaneous or oral administration of rhIL-11 modulated the contact hypersensitivity response. Cytokine (2000) 0.75
Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory protein. Clin Immunol (1999) 0.75